11

resultado(s)

Palabra(s)
Tipo de publicación
Ámbito político
Autor
Palabra clave
legislación sanitaria
Fecha

Health and safety in the workplace of the future

16-09-2019

The note identifies future risks to the physical and mental health and safety of workers that are attributable to technology-driven changes in the workplace and looks at possible legislative responses and further action.

The note identifies future risks to the physical and mental health and safety of workers that are attributable to technology-driven changes in the workplace and looks at possible legislative responses and further action.

    Briefing pdf  
Autor externo

David Cabrelli, Richard Graveling

Public expectations and EU policies - Health and social security

30-06-2016

Almost two thirds of EU citizens would like to see more EU engagement in the areas of health and social security. The EU's main role in these policies is to support and complement the activities of Member States, and it can encourage cooperation and best practice. EU health policy aims to foster good health, protect citizens from health threats and support dynamic health systems. Social policy promotes social cohesion equality as well as solidarity through adequate, accessible and financially sustainable ...

Almost two thirds of EU citizens would like to see more EU engagement in the areas of health and social security. The EU's main role in these policies is to support and complement the activities of Member States, and it can encourage cooperation and best practice. EU health policy aims to foster good health, protect citizens from health threats and support dynamic health systems. Social policy promotes social cohesion equality as well as solidarity through adequate, accessible and financially sustainable social protection systems and social inclusion policies. The EU encourages national pension reforms to ensure they are both adequate and sustainable. In the EU budget, the Health Programme 2014-2020 is the only programme specifically created for this policy area, but other programmes contribute in part to health objectives. EU spending on social security is tied to labour market measures.

    Briefing pdf  

Cross-Cutting Effects of the EU´s Preferential Trade Agreements (PTAs) on Developing Economies

15-06-2015

The world has seen rapid growth of preferential trade and investment agreements (PTAs) that, by definition, aim to go beyond the existing WTO obligations of the parties. With this growth comes the danger of incompatible obligations as these PTAs overlap within a country. This study examines the sources of overlap in various PTAs and the compliance costs that PTAs may create for a developing country, with a special focus on the agricultural realm. Examining the reality of divergent SPS standards, ...

The world has seen rapid growth of preferential trade and investment agreements (PTAs) that, by definition, aim to go beyond the existing WTO obligations of the parties. With this growth comes the danger of incompatible obligations as these PTAs overlap within a country. This study examines the sources of overlap in various PTAs and the compliance costs that PTAs may create for a developing country, with a special focus on the agricultural realm. Examining the reality of divergent SPS standards, we conclude that better-targeted “Aid for Trade” and regulatory streamlining within the EU can help to mitigate compliance costs in developing countries. Additionally, involvement of the private sector at an earlier stage in PTA negotiations may also help to clarify compliance costs and build their mitigation into the agreements.

    Estudio pdf  
Autor externo

Christopher HARTWELL (CASE - Center for Social and Economic Research, Poland)

ENVI Relevant Legislative Areas of the EU-US Trade and Investment Partnership Negotiations (TTIP)

05-11-2014

This study, prepared by Policy Department A, aims to support Members of the Committee on Environment, Public Health and Food Safety (ENVI) in monitoring on-going negotiations for a Transatlantic Trade and Investment Partnership (TTIP). It analyses the main differences between EU and US legislation in eight areas, namely: human medicines and medical devices, cosmetics, food and nutrition, sanitary and phyto-sanitary, nanomaterials, cloning, raw materials and energy, and motor vehicles. Existing collaboration ...

This study, prepared by Policy Department A, aims to support Members of the Committee on Environment, Public Health and Food Safety (ENVI) in monitoring on-going negotiations for a Transatlantic Trade and Investment Partnership (TTIP). It analyses the main differences between EU and US legislation in eight areas, namely: human medicines and medical devices, cosmetics, food and nutrition, sanitary and phyto-sanitary, nanomaterials, cloning, raw materials and energy, and motor vehicles. Existing collaboration between the EU and US, progress already achieved in the negotiations and potential future developments in these areas are also addressed.

    Estudio pdf  
Autor externo

Shailendra Mudgal, Katherine Salès, Alice Landowski, Otto Kern, Juliette Mansard, Christiane Gerstetter, Max Grünig, Elizabeth Dooley, Elizabeth Tedsen, Martin Nesbit, Kamila Paquel and Sirini Withana

Proceedings of the Workshop on "Prevention and Healthy Life"

16-06-2014

This report summarises the presentations and discussions at the Workshop on ‘Prevention and Healthy Life’, held at the European Parliament in Brussels, on Tuesday 4 March 2014. The aim of the workshop was to discuss the main challenges and future perspectives related to the topic of health promotion and disease prevention. The workshop was hosted by MEP Mr Alojz PETERLE (EPP, SL), Co-chair of the Health Working Group within the ENVI Committee.

This report summarises the presentations and discussions at the Workshop on ‘Prevention and Healthy Life’, held at the European Parliament in Brussels, on Tuesday 4 March 2014. The aim of the workshop was to discuss the main challenges and future perspectives related to the topic of health promotion and disease prevention. The workshop was hosted by MEP Mr Alojz PETERLE (EPP, SL), Co-chair of the Health Working Group within the ENVI Committee.

    Estudio pdf  
Autor externo

Michael Hübel (DG Health and Consumers, European Commission), Sabine Rohrmann (Institute of Social and Preventing Medicine, University of Zurich, Switzerland), Marjan Videnšek (Foundation Zavod Preporod, Slovenia) and Karl Kuhn (European Network for Workplace Health Promotion - ENWHP)

Safe and innovative medical devices

17-10-2013

Innovation in medical devices benefits patients, doctors and the medical technology industry. The European Commission has proposed legis­lation aimed at enhancing safety, traceability, and transparency without inhibiting innovation.

Innovation in medical devices benefits patients, doctors and the medical technology industry. The European Commission has proposed legis­lation aimed at enhancing safety, traceability, and transparency without inhibiting innovation.

    De un vistazo pdf  

The Consequences of REACH for SMEs

15-10-2013

This note examines the consequences of REACH legislation for Small and Medium-Sized Enterprises (SMEs) since its entry into force in June 2007. It looks at impacts on the internal organisation of firms (including human resources), on strategy and on business activities. We also assess the experience of SMEs with available support and the perceived added value of REACH for SMEs. Our findings are based on a review of the literature and a set of interviews to a sample of firms.

This note examines the consequences of REACH legislation for Small and Medium-Sized Enterprises (SMEs) since its entry into force in June 2007. It looks at impacts on the internal organisation of firms (including human resources), on strategy and on business activities. We also assess the experience of SMEs with available support and the perceived added value of REACH for SMEs. Our findings are based on a review of the literature and a set of interviews to a sample of firms.

    Estudio pdf  
Autor externo

Jacques Pelkmans, Lorna Schrefler and Ineke Gubbels (CEPS)

Proceedings of the Workshop on "Electronic Cigarettes"

15-05-2013

This report summarises the presentations and discussions at the Workshop on electronic cigarettes, held on 7 May 2013 at the European Parliament. The aims of the workshop were to exchange information on how different jurisdictions deal with the regulation of the electronic cigarette and to be informed on the status of the scientific evidence concerning long-term health effects. The workshop was hosted by MEP Linda McAvan (S&D, UK), ENVI Committee, Rapporteur on Tobacco Products Directive.

This report summarises the presentations and discussions at the Workshop on electronic cigarettes, held on 7 May 2013 at the European Parliament. The aims of the workshop were to exchange information on how different jurisdictions deal with the regulation of the electronic cigarette and to be informed on the status of the scientific evidence concerning long-term health effects. The workshop was hosted by MEP Linda McAvan (S&D, UK), ENVI Committee, Rapporteur on Tobacco Products Directive.

    Estudio pdf  
Autor externo

Contributing experts: Martin Seychell (DG SANCO, European Commission), Roberto Bertollini (WHO representative to the European Union), Jeremy Mean (Access and information for medicines and standards group manager, Vigilance and Risk Management of Medicines, London, the UK), Kerstin Stephan (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM, DE), Kristiina Pellas (Finnish Medicines Agency, FI), Francesco Blasi (European Respiratory Society), Charlotta Pisinger (Research Centre for Prevention and Health, Copenhagen, DK), Jean-Francois Etter (Faculty of Medicine, University of Geneva, CH) and Hans Christian Holy (Interessengemeinschaft E-Dampfen, German e-cigarettes users association, DE) Authors: Matthijs Versteegh and Wija Oortwijn (ECORYS Netherlands B.V., Rotterdam, The Netherlands)

EU policy on endocrine disruptors

07-03-2013

Endocrine disruptors (EDs) are substances that disturb the functioning of hormones, and are associated with various human health problems, including reduced fertility and reproductive abnormalities. EDs can act at very low doses and are especially dangerous during pregnancy and in infancy.

Endocrine disruptors (EDs) are substances that disturb the functioning of hormones, and are associated with various human health problems, including reduced fertility and reproductive abnormalities. EDs can act at very low doses and are especially dangerous during pregnancy and in infancy.

    De un vistazo pdf  

Proceedings of the Workshop on "Endocrine Disruptors and Impact on Health"

14-09-2012

This report summarises the presentations and discussions at the Workshop on Endocrine Disruptors and Health, held at the European Parliament in Brussels, on Tuesday 18 September 2012. The aim of the workshop was to better understand the impacts of endocrine disruptors on health and to provide input into the ongoing policy discussions at EU-level. The workshop was hosted and chaired by MEP Åsa Westlund (S&D, SE), Rapporteur for the Parliament’s own initiative report on the “Protection of public health ...

This report summarises the presentations and discussions at the Workshop on Endocrine Disruptors and Health, held at the European Parliament in Brussels, on Tuesday 18 September 2012. The aim of the workshop was to better understand the impacts of endocrine disruptors on health and to provide input into the ongoing policy discussions at EU-level. The workshop was hosted and chaired by MEP Åsa Westlund (S&D, SE), Rapporteur for the Parliament’s own initiative report on the “Protection of public health from endocrine disruptors”.

    Estudio pdf  
Autor externo

Gustaaf Borchardt (European Commission, DG Environment) , Tapani Piha (European Commission, DG SANCO) , Jacqueline McGlade (European Environment Agency) , Peter Korytar (European Commission, DG Environment) , Jim Bridges (Univ. of Surrey) , Andreas Kortenkamp (Institute for the Environment, Brunel University, London) , Alberto Mantovani (National Health Institute of Health, ISS, Italy) , Peter Smith (Programme Product Stewardship, CEFIC) and Yannick Vicaire (Réseau Environment Santé, RES)

Página siguiente

Próximos actos

04-03-2021
ICM International Women's Day 2021
Otro acto -
FEMM
04-03-2021
EPRS online policy roundtable: Unpacking the latest Eurobarometer survey
Otro acto -
EPRS
15-03-2021
EPRS online Book Talk with Vivien Schmidt: Legitimacy and power in the EU
Otro acto -
EPRS
Ver todas

Socios

Ver la lista completa